Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Stable Gastric Pentadecapeptide BPC 157: Prompt Particular Activation of Collateral Pathways

Author(s): Predrag Sikiric*, Slaven Gojkovic, Mario Knezevic, Marijan Tepes, Sanja Strbe, Jaksa Vukojevic, Antonija Duzel, Tamara Kralj, Ivan Krezic, Helena Zizek, Katarina Oroz, Hrvoje Vranes, Ivan Maria Smoday, Luka Kalogjera, Josipa Vlainic, Antonio Kokot, Ivana Jurjevic, Alenka Boban Blagaic, Anita Skrtic* and Sven Seiwerth

Volume 30, Issue 13, 2023

Published on: 01 November, 2022

Page: [1568 - 1573] Pages: 6

DOI: 10.2174/0929867329666221005111553

« Previous
[1]
Sikiric, P.; Skrtic, A.; Gojkovic, S.; Krezic, I.; Zizek, H.; Lovric, E.; Sikiric, S.; Knezevic, M.; Strbe, S.; Milavic, M.; Kokot, A.; Boban, B.A.; Seiwerth, S. Gastric pentadecapeptide BPC 157 in cytoprotec-tion to resolve major vessel occlusion disturbances, pringle maneuver and Budd Chiari syndrome. World J. Gastroenterol., 2022, 28, 23-46.
[http://dx.doi.org/10.3748/wjg.v28.i1.23] [PMID: 35125818]
[2]
Seiwerth, S.; Milavic, M.; Vukojevic, J.; Gojkovic, S.; Krezic, I.; Vuletic, L.B.; Pavlov, K.H.; Petrovic, A.; Sikiric, S.; Vranes, H.; Prtoric, A.; Zizek, H.; Durasin, T.; Dobric, I.; Staresinic, M.; Strbe, S.; Knezevic, M.; Sola, M.; Kokot, A.; Sever, M.; Lovric, E.; Skrtic, A.; Blagaic, A.B.; Sikiric, P. Stable gastric pentadecapeptide BPC 157 and wound healing. Front. Pharmacol., 2021, 12, 627533.
[http://dx.doi.org/10.3389/fphar.2021.627533] [PMID: 34267654]
[3]
Vukojević, J.; Siroglavić, M.; Kašnik, K.; Kralj, T.; Stanćić, D.; Kokot, A.; Kolarić, D.; Drmić, D.; Sev-er, A.Z.; Barišić, I.; Šuran, J.; Bojić, D.; Patrlj, M.H.; Sjekavica, I.; Pavlov, K.H.; Vidović, T.; Vlainić, J.; Stupnišek, M.; Seiwerth, S.; Sikirić, P. Rat Inferior Caval Vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157. Vascul. Pharmacol., 2018, 106, 54-66.
[http://dx.doi.org/10.1016/j.vph.2018.02.010] [PMID: 29510201]
[4]
Kolovrat, M.; Gojkovic, S.; Krezic, I.; Malekinusic, D.; Vrdoljak, B.; Kovac, K.K.; Kralj, T.; Drmic, D.; Barisic, I.; Pavlov, K.H.; Petrovic, A.; Duzel, A.; Knezevic, M.; Mirkovic, I.; Kokot, A.; Blagaic, A.B.; Seiwerth, S.; Sikiric, P. Pentadecapeptide BPC 157 resolves Pringle Maneuver in rats, both is-chemia and reperfusion. World J. Hepatol., 2020, 12(5), 12-196.
[http://dx.doi.org/10.4254/wjh.v12.i5.184] [PMID: 32547687]
[5]
Duzel, A.; Vlainic, J.; Antunovic, M.; Malekinusic, D.; Vrdoljak, B.; Samara, M.; Gojkovic, S.; Krezic, I.; Vidovic, T.; Bilic, Z.; Knezevic, M.; Sever, M.; Lojo, N.; Kokot, A.; Kolovrat, M.; Drmic, D.; Vukojevic, J.; Kralj, T.; Kasnik, K.; Siroglavic, M.; Seiwerth, S.; Sikiric, P. Stable gastric pentade-capeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World J. Gastroenterol., 2017, 23(48), 8465-8488.
[http://dx.doi.org/10.3748/wjg.v23.i48.8465] [PMID: 29358856]
[6]
Vukojević, J.; Vrdoljak, B.; Malekinušić, D.; Siroglavić, M.; Milavić, M.; Kolenc, D.; Boban Blagaić, A.; Batelja, L.; Drmić, D.; Seiverth, S.; Sikirić, P. The effect of pentadecapeptide BPC 157 on hippo-campal ischemia/reperfusion injuries in rats. Brain Behav., 2020, 10(8), e01726.
[http://dx.doi.org/10.1002/brb3.1726] [PMID: 32558293]
[7]
Gojkovic, S.; Krezic, I.; Vrdoljak, B.; Malekinusic, D.; Barisic, I.; Petrovic, A.; Pavlov, K.H.; Kolovrat, M.; Duzel, A.; Knezevic, M.; Kovac, K.K.; Drmic, D.; Vuletic, L.B.; Kokot, A.; Blagaic, A.B.; Sei-werth, S.; Sikiric, P. Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-chiari syndrome model in rats. World J. Gastrointest. Pathophysiol., 2020, 11(1), 1-19.
[http://dx.doi.org/10.4291/wjgp.v11.i1.1] [PMID: 32226643]
[8]
Gojkovic, S.; Krezic, I.; Vranes, H.; Zizek, H.; Drmic, D.; Horvat Pavlov, K.; Petrovic, A.; Batelja Vuletic, L.; Milavic, M.; Sikiric, S.; Stilinovic, I.; Samara, M.; Knezevic, M.; Barisic, I.; Sjekavica, I.; Lovric, E.; Skrtic, A.; Seiwerth, S.; Sikiric, P. BPC 157 therapy and the permanent occlusion of the superior sagittal sinus in rat: Vascular recruitment. Biomedicines, 2021, 9(7), 744.
[http://dx.doi.org/10.3390/biomedicines9070744] [PMID: 34203464]
[9]
Knezevic, M.; Gojkovic, S.; Krezic, I.; Zizek, H.; Malekinusic, D.; Vrdoljak, B.; Vranes, H.; Knezevic, T.; Barisic, I.; Horvat Pavlov, K.; Drmic, D.; Staroveski, M.; Djuzel, A.; Rajkovic, Z.; Kolak, T.; Kocman, I.; Lovric, E.; Milavic, M.; Sikiric, S.; Tvrdeic, A.; Patrlj, L.; Strbe, S.; Kokot, A.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Occlusion of the superior mesenteric artery in rats reversed by collateral pathways activation: Gastric pentadecapeptide BPC 157 therapy counteracts multiple or-gan dysfunction syndrome; intracranial, portal and caval hypertension; and aortal hypotension. Biomedicines, 2021, 9(6), 609.
[http://dx.doi.org/10.3390/biomedicines9060609] [PMID: 34073625]
[10]
Knezevic, M.; Gojkovic, S.; Krezic, I.; Zizek, H.; Vranes, H.; Malekinusic, D.; Vrdoljak, B.; Knezevic, T.; Horvat Pavlov, K.; Drmic, D.; Staroveski, M.; Djuzel, A.; Rajkovic, Z.; Kolak, T.; Lov-ric, E.; Milavic, M.; Sikiric, S.; Barisic, I.; Tepes, M.; Tvrdeic, A.; Patrlj, L.; Strbe, S.; Sola, M.; Situm, A.; Kokot, A.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Complex syndrome of the complete occlusion of the end of the superior mesenteric vein, opposed with the stable gastric pentadecapeptide BPC 157 in rats. Biomedicines, 2021, 9(8), 1029.
[http://dx.doi.org/10.3390/biomedicines9081029] [PMID: 34440233]
[11]
Knezevic, M.; Gojkovic, S.; Krezic, I.; Zizek, H.; Malekinusic, D.; Vrdoljak, B.; Knezevic, T.; Vranes, H.; Drmic, D.; Staroveski, M.; Djuzel, A.; Rajkovic, Z.; Kolak, T.; Lovric, E.; Milavic, M.; Sikiric, S.; Tvrdeic, A.; Patrlj, L.; Strbe, S.; Sola, M.; Situm, A.; Kokot, A.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Occluded superior mesenteric artery and vein. Therapy with the stable gastric pentade-capeptide BPC 157. Biomedicines, 2021, 9(7), 792.
[http://dx.doi.org/10.3390/biomedicines9070792] [PMID: 34356860]
[12]
Kralj, T.; Kokot, A.; Zlatar, M.; Masnec, S.; Kasnik Kovac, K.; Milkovic, P.M.; Batelja Vuletic, L.; Giljanovic, A.; Strbe, S.; Sikiric, S.; Balog, S.; Sontacchi, B.; Sontacchi, D.; Buljan, M.; Lovric, E.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Stable gastric pentadecapeptide BPC 157 therapy of rat glaucoma. Biomedicines, 2021, 10(1), 89.
[http://dx.doi.org/10.3390/biomedicines10010089] [PMID: 35052769]
[13]
Gojkovic, S.; Krezic, I.; Vranes, H.; Zizek, H.; Drmic, D.; Batelja Vuletic, L.; Milavic, M.; Sikiric, S.; Stilinovic, I.; Simeon, P.; Knezevic, M.; Kolak, T.; Tepes, M.; Simonji, K.; Strbe, S.; Nikolac, G.N.; Barisic, I.; Oreskovic, E.G.; Lovric, E.; Kokot, A.; Skrtic, A.; Boban, B.A.; Seiwerth, S.; Sikiric, P. Robert’s intragastric alcohol induced gastric lesion model as an escalated general peripheral and cen-tral syndrome, counteracted by the stable gastric pentadecapeptide BPC 157. Biomedicines, 2021, 9(10), 1300.
[http://dx.doi.org/10.3390/biomedicines9101300] [PMID: 34680419]
[14]
Strbe, S.; Gojkovic, S.; Krezic, I.; Zizek, H.; Vranes, H.; Barisic, I.; Strinic, D.; Orct, T.; Vukojevic, J.; Ilic, S.; Lovric, E.; Muzinic, D.; Kolenc, D.; Filipčić, I.; Zoricic, Z.; Marcinko, D.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Over dose lithium toxicity as an occlusive like syndrome in rats and gastric pentadecapeptide BPC 157. Biomedicines, 2021, 9(11), 1506.
[http://dx.doi.org/10.3390/biomedicines9111506] [PMID: 34829735]
[15]
Tepes, M.; Gojkovic, S.; Krezic, I.; Zizek, H.; Vranes, H.; Madzar, Z.; Santak, G.; Batelja, L.; Milavic, M.; Sikiric, S.; Kocman, I.; Simonji, K.; Samara, M.; Knezevic, M.; Barisic, I.; Lovric, E.; Strbe, S.; Kokot, A.; Sjekavica, I.; Kolak, T.; Skrtic, A.; Seiwerth, S.; Boban, B.A.; Sikiric, P. Stable gastric pentadecapeptide BPC 157 therapy for primary abdominal compartment syndrome in rats. Front. Pharmacol., 2021, 12, 718147.
[http://dx.doi.org/10.3389/fphar.2021.718147] [PMID: 34966273]
[16]
Smoday, I.M.; Petrovic, I.; Kalogjera, L.; Vranes, H.; Zizek, H.; Krezic, I.; Gojkovic, S.; Skorak, I.; Hriberski, K.; Brizic, I.; Kubat, M.; Strbe, S.; Barisic, I.; Sola, M.; Lovric, E.; Lozic, M.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Therapy effect of the stable gastric pentadecapeptide BPC 157 on acute pancreatitis as vascular failure induced severe peripheral and central syndrome in rats. Biomedicines, 2022, 10(6), 1299.
[http://dx.doi.org/10.3390/biomedicines10061299] [PMID: 35740321]
[17]
Barisic, I.; Balenovic, D.; Udovicic, M.; Bardak, D.; Strinic, D.; Vlainić, J.; Vranes, H.; Smoday, I.M.; Krezic, I.; Milavic, M.; Sikiric, S.; Uzun, S.; Zivanovic Posilovic, G.; Strbe, S.; Vukoja, I.; Lovric, E.; Lozic, M.; Sever, M.; Lovric Bencic, M.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Stable gas-tric pentadecapeptide BPC 157 may counteract myocardial infarction induced by isoprenaline in rats. Biomedicines, 2022, 10(2), 265.
[http://dx.doi.org/10.3390/biomedicines10020265] [PMID: 35203478]
[18]
Robert, A. Cytoprotection by prostaglandins. Gastroenterology, 1979, 77(4), 761-767.
[http://dx.doi.org/10.1016/0016-5085(79)90235-X] [PMID: 38173]
[19]
Szabo, S.; Trier, J.S.; Brown, A.; Schnoor, J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology, 1985, 88(1), 228-236.
[http://dx.doi.org/10.1016/S0016-5085(85)80176-1] [PMID: 3871087]
[20]
Masnec, S.; Kokot, A.; Zlatar, M.; Kalauz, M.; Kunjko, K.; Radic, B.; Klicek, R.; Drmic, D.; Lazic, R.; Brcic, L.; Radic, R.; Ivekovic, R.; Seiwerth, S.; Sikiric, P. Perforating corneal injury in rat and pen-tadecapeptide BPC 157. Exp. Eye Res., 2015, 136, 9-15.
[http://dx.doi.org/10.1016/j.exer.2015.04.016] [PMID: 25912999]
[21]
Sikiric, P.; Seiwerth, S.; Rucman, R.; Turkovic, B.; Rokotov, D.; Brcic, L.; Sever, M.; Klicek, R.; Radic, B.; Drmic, D.; Ilic, S.; Kolenc, D.; Aralica, G.; Stupnisek, M.; Suran, J.; Barisic, I.; Dzidic, S.; Vrcic, H.; Sebecic, B. Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr. Pharm. Des., 2014, 20(7), 1126-1135.
[http://dx.doi.org/10.2174/13816128113190990411] [PMID: 23755725]
[22]
Stupnisek, M.; Kokot, A.; Drmic, D.; Hrelec Patrlj, M.; Zenko Sever, A.; Kolenc, D.; Radic, B.; Su-ran, J.; Bojic, D.; Vcev, A.; Seiwerth, S.; Sikiric, P. Pentadecapeptide BPC 157 reduces bleeding and thrombocytopenia after amputation in rats treated with heparin, warfarin, L-NAME and L-arginine. PLoS One, 2015, 10(4), e0123454.
[http://dx.doi.org/10.1371/journal.pone.0123454] [PMID: 25897838]
[23]
Konosic, S.; Petricevic, M.; Ivancan, V.; Konosic, L.; Goluza, E.; Krtalic, B.; Drmic, D.; Stupnisek, M.; Seiwerth, S.; Sikiric, P. Intragastric application of aspirin, clopidogrel, cilostazol, and BPC 157 in rats: Platelet aggregation and blood clot. Oxid. Med. Cell. Longev., 2019, 2019, 9084643.
[http://dx.doi.org/10.1155/2019/9084643] [PMID: 31976029]
[24]
Hsieh, M.J.; Liu, H.T.; Wang, C.N.; Huang, H.Y.; Lin, Y.; Ko, Y.S.; Wang, J.S.; Chang, V.H.S.; Pang, J.H.S. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J. Mol. Med., 2017, 95(3), 323-333.
[http://dx.doi.org/10.1007/s00109-016-1488-y] [PMID: 27847966]
[25]
Hsieh, M.J.; Lee, C.H.; Chueh, H.Y.; Chang, G.J.; Huang, H.Y.; Lin, Y.; Pang, J.H.S. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci. Rep., 2020, 10(1), 17078.
[http://dx.doi.org/10.1038/s41598-020-74022-y] [PMID: 33051481]
[26]
Zlatar, M.; Kokot, A.; Vuletic, L.B.; Masnec, S.; Kralj, T.; Perisa, M.M.; Barisic, I.; Radic, B.; Mila-novic, K.; Drmic, D.; Seiwerth, S.; Sikiric, P.; Zlatar, M.; Sikiric, P.; Masnec, S. BPC 157 as a therapy for retinal ischemia induced by retrobulbar application of L-NAME in rats. Front. Pharmacol., 2021, 12, 632295.
[http://dx.doi.org/10.3389/fphar.2021.632295] [PMID: 34177567]
[27]
Sikiric, P.; Seiwerth, S.; Rucman, R.; Turkovic, B.; Rokotov, D.S.; Brcic, L.; Sever, M.; Klicek, R.; Radic, B.; Drmic, D.; Ilic, S.; Kolenc, D.; Aralica, G.; Safic, H.; Suran, J.; Rak, D.; Dzidic, S.; Vrcic, H.; Sebecic, B. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. Curr. Pharm. Des., 2013, 19(1), 76-83.
[PMID: 22950504]
[28]
Park, J.M.; Lee, H.J.; Sikiric, P.; Hahm, K.B. BPC 157 rescued NSAID-cytotoxicity via stabilizing intestinal permeability and enhancing cytoprotection. Curr. Pharm. Des., 2020, 26(25), 2971-2981.
[http://dx.doi.org/10.2174/1381612826666200523180301] [PMID: 32445447]
[29]
Seiwerth, S.; Rucman, R.; Turkovic, B.; Sever, M.; Klicek, R.; Radic, B.; Drmic, D.; Stupnisek, M.; Misic, M.; Vuletic, L.B.; Pavlov, K.H.; Barisic, I.; Kokot, A.; Japjec, M.; Blagaic, A.B.; Tvrdeic, A.; Rokotov, D.S.; Vrcic, H.; Staresinic, M.; Sebecic, B.; Sikiric, P. BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Curr. Pharm. Des., 2018, 24(18), 1972-1989.
[http://dx.doi.org/10.2174/1381612824666180712110447] [PMID: 29998800]
[30]
Deek, S.A. BPC 157 as potential treatment for COVID-19. Med. Hypotheses, 2022, 158, 110736.
[http://dx.doi.org/10.1016/j.mehy.2021.110736] [PMID: 34798584]
[31]
Kang, E.A.; Han, Y.M.; An, J.M.; Park, Y.J.; Sikiric, P.; Kim, D.H.; Kwon, K.A.; Kim, Y.J.; Yang, D.; Tchah, H.; Hahm, K.B. BPC157 as potential agent rescuing from cancer cachexia. Curr. Pharm. Des., 2018, 24(18), 1947-1956.
[http://dx.doi.org/10.2174/1381612824666180614082950] [PMID: 29898649]
[32]
Xu, C.; Sun, L.; Ren, F.; Huang, P.; Tian, Z.; Cui, J.; Zhang, W.; Wang, S.; Zhang, K.; He, L.; Zhang, W.; Zhang, C.; Hao, Q.; Zhang, Y.; Li, M.; Li, W. Preclinical safety evaluation of body protective compound 157, a potential drug for treating various wounds. Regul. Toxicol. Pharmacol., 2020, 114, 104665.
[http://dx.doi.org/10.1016/j.yrtph.2020.104665] [PMID: 32334036]

Rights & Permissions Print Cite
Article Metrics
34
2
© 2024 Bentham Science Publishers | Privacy Policy